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Quality assuranceAbstract Proposals to improve implementation, monitoring and evaluation of breast, cervi-
cal and colorectal cancer screening programmes have been developed in a European project
involving scientists and professionals experienced in cancer registration (EUROCOURSE).
They call for a clear and more active role for cancer registries through better interfaces with
cancer screening programmes and adapting data contents of cancer registries for evaluation
purposes. Cancer registries are recognised as essential for adequate evaluation of cancer
screening programmes, but they are not involved in screening evaluation in several
European countries. This is a key barrier to improving the effectiveness of programmes across
Europe.
The variation in Europe in the implementation of cancer screening offers a unique opportunity
to learn from best practices in collaboration between cancer registries and screening pro-
grammes.
Population-based cancer registries have experience and tools in collecting and analysing rele-
vant data, e.g. for diagnostic and therapeutic determinants of mortality. In order to accelerate
improvements in cancer control we argue that cancer registries should take co-responsibility in
promoting effective screening evaluation in Europe. Additional investments are vital to fur-
ther development of infrastructures and activities for screening evaluation and monitoring
in the national settings and also at the pan-European level. The EUROCOURSE project alsoicle/pii/
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screening programmes across Europe through standardising routine data collection and anal-
ysis, and deﬁnitions for key performance indicators for screening registers. Data linkage
between cancer and screening registers and other repositories of demographic data and cause
of death and where available clinical registers is key to implementing the European screening
standards and thereby reducing the burden of disease through early detection.
Greater engagement of cancer registries in this collaborative effort is also essential to develop
adequate evaluation of innovations in cancer prevention and care.
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